KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd's wholly-owned subsidiary MGRC Therapeutics Sdn Bhd has entered into a collaboration with South Korea-listed Dx&Vx Co Ltd to drive the development and supply of advanced genomic testing services.